(4-(Pyridin-2-ylcarbamoyl)phenyl)boronic acid, 97.0%, 250mg

4-(4-Heptyloxybenzoyl)-2-methylpyridine, 97.0%, 1g

(1R,3S)-3-(1,3-DIOXOISOINDOLIN-2-YL)CYCLOHEXYL ACETATE, 95.0%, 100mg

Olmesartan, 98%, 500mg

4,4,4-Trifluoro-1-(3-methoxy-phenyl)-butane-1,3-dione, 97%, 5g

(-)-4,5-Bis[hydroxy(diphenyl)methyl]-2,2-dimethyl-1,3-dioxolane>97.0%(HPLC)5g

[2-(4-methylpiperazin-1-yl)-2-(3-thienyl)ethyl]amine, 95.0%, 250mg

7-Bromo-5-chloroindole, 95.0%, 1g

Butyl 2-cyanoacrylate, 95.0%, 100g

4-Methoxy-2-methylbenzonitrile, 95.0%, 5g

5-Bromo-2-fluoronicotinonitrile, 98.0%, 25g

(3-phenylpropyl)(propyl)amine hydrochloride, 95.0%, 10g

2-Amino-5-methyloxazole-4-carboxylic acid ethylester, 95.0%, 1g